Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Issues Warning About Compounding Pharmacies Using Supplement-Grade Glutathione for IV Products
Follow us on:
Breaking News
September 1, 2026
Breaking News
Breaking News

FDA Issues Warning About Compounding Pharmacies Using Supplement-Grade Glutathione for IV Products

 
FDA Issues Warning About Compounding Pharmacies Using Supplement-Grade Glutathione for IV Products

The agency reported that at least 30 patients experienced adverse events linked to IV glutathione administration.
Read More >>

Top Headlines

Market Updates

Lallemand Acquires BIO-CAT

The acquisition will significantly boost Lallemand's capabilities in enzymes and microbials.

Market Updates

Truvant Acquires Multi-Pak Packaging, a Specialist in Vitamins, Supplements, and OTC

The acquisition deepens Truvant's ability to support health, wellness, and beauty brands.

Market Updates

Momentous Announces Nationwide Rollout at Target Stores

The expansion follows the brand's entry into hundreds of The Vitamin Shoppe locations earlier in 2026.

Market Updates

Cymbiotika Partners with Hundred Health on Biomarker Test Discount

Customers who purchase the brand's supplements can add a biomarker test, personalized protocol, and other Hundred Services at checkout for a fraction of the price.

Research

Aspurūs Shatavari Supports Menopause Symptoms Within Two Weeks: Study  

The study found significant improvements in self-reported symptoms related to hot flashes, sexual health, and physiological well-being.

Research

OmegaQuant Receives NIH Grant to Study Fatty Acid Biomarkers for Age-Related Macular Degeneration and Glaucoma

The newly funded project will create machine learning algorithms to determine if fatty acid patterns can help predict risk factors for eye conditions.